X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

HUMAN PATHOLOGY

期刊標題檢索 HUM PATHOL 最新評論: General parts include title, abstract, introduction, methods, results,... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[HUMAN PATHOLOGY]您好,您是該頁面的第 35192 位訪客。

期刊簡介
期刊名稱HUMAN PATHOLOGY HUMAN PATHOLOGY
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
9.4

期刊簡稱HUM PATHOL
ISSN0046-8177
E-ISSN1532-8392
h-index131
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.300.9361.038
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q149 / 208

自引率 (2023-2024)7.40%自引率趨勢
掲載範囲
Human Pathology is designed to bring information of clinicopathologic significance to human disease to the laboratory and clinical physician. It presents information drawn from morphologic and clinical laboratory studies with direct relevance to the understanding of human diseases. Papers published concern morphologic and clinicopathologic observations, reviews of diseases, analyses of problems in pathology, significant collections of case material and advances in concepts or techniques of value in the analysis and diagnosis of disease. Theoretical and experimental pathology and molecular biology pertinent to human disease are included. This critical journal is well illustrated with exceptional reproductions of photomicrographs and microscopic anatomy.
官方網站http://www.humanpathol.com/
在線稿件提交https://www.editorialmanager.com/YHUPA
開放訪問No
出版商W.B. Saunders Ltd
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1970
每年文章數171每年文章數趨勢
黃金OA百分比15.04%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PATHOLOGYSCIEQ231/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0046-8177%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-6 Week(s)
來自Elsevier的數據: Average 6.6 Week(s)
競爭力 *來自作者的數據: Easy
來自Elsevier的數據: 37%
在線文章發布時間來自Elsevier的數據: Average 11.7 Week(s)
參考鏈接
相關期刊 【HUMAN PATHOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF PATHOLOGYH-index: 258

    CiteScore: 11.40
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports321413
    DISEASE MARKERS95481
    PATHOLOGY RESEARCH AND PRACTICE68898
    LABORATORY INVESTIGATION67715
    JOURNAL OF PATHOLOGY65840
    AMERICAN JOURNAL OF PATHOLOGY61290
    Diagnostic Pathology44533
    ACTA NEUROPATHOLOGICA44276
    PATHOLOGY & ONCOLOGY RESEARCH43803
    MODERN PATHOLOGY41823
  •  

    HUMAN PATHOLOGY HUMAN PATHOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [HUMAN PATHOLOGY] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:50:15 評論於
General parts include title, abstract, introduction, methods, results, conclusion, figures (including figure titles and captions), acknowledgments, conflicts of interest, references, etc
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:54:52 評論於
Suggestion is to complete the main results section, then you can start writing the article, or you can start thinking about the article after obtaining the main phenotype data or completing the design of the project, and write it while doing it
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:17:25 評論於
What are the main components of a research article?
(0) 讚! | 八坂篷蔚

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 08:15:52 評論於
At what stage of the experiment is it more appropriate to start writing the article?
(0) 讚! | 平原文波

作者: Miriam Walker


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-09 22:53:00 評論於
Can we publish this case?
(0) 讚! | Miriam Walker

作者: Jared Meredith


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-17 09:59:40 評論於
Does this magazine accept reviews?
(0) 讚! | Jared Meredith

作者: 山芙小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-09 19:17:31 評論於
Will the addition of transcriptomics and immunohistochemistry validation also be rejected?
(0) 讚! | 山芙小仙女

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-09 12:54:48 評論於
It's a lot easier
(0) 讚! | 法慧和同

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-09 10:20:43 評論於
Built on bioinformatics, quantitative PCR, WB, or IHC are all applicable
(0) 讚! | 法慧和同

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-09 08:58:31 評論於
The arrangement is too simple, we need to add some mechanisms
(0) 讚! | 法慧和同

作者: 天际舒扬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-26 08:48:42 評論於
Is there a layout fee for the magazine?
(0) 讚! | 天际舒扬

作者: 青曼酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-02 11:48:00 評論於
Bioinformatics rejected in seconds!
(0) 讚! | 青曼酱大魔王

作者: 哲茂小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-02 21:24:11 評論於
How long does it usually take for everyone with the editor? It's been 5 days already, is it going to be a tragedy?
(0) 讚! | 哲茂小哥哥

作者: 丁亥超级甜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-31 11:10:01 評論於
Review speed: 3.0 | Submission success rate: 25.0 Experience sharing: Submitted an immunohistochemistry article, rejected by the editor in 10 days
(0) 讚! | 丁亥超级甜

作者: 彤霞少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-30 10:44:20 評論於
Is it difficult to submit articles to this magazine?
(0) 讚! | 彤霞少女

作者: 寒阴访波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-19 15:25:57 評論於
My article focuses on clinical phenotype prognosis and cellular level pathways. Does it match with this journal? I noticed that this journal seems to rarely cover pathways
(0) 讚! | 寒阴访波

作者: 百花冰海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-07-10 21:40:22 評論於
The first review comments given in 6 weeks did not mention whether to accept or reject, only asked for revisions. I did not have much hope, but I strictly followed the editor's suggestions and replied within 2 months, although it was actually 1.5 months later. I thought I still had to wait for another month, but surprisingly, I received feedback just 5 days later, asking for minor revisions. I made the changes and it was accepted right away. Happiness came unexpectedly. The magazine's decision to accept the revised draft was quickly made by the editor, so the process was fast. I wasted over a month due to not seeing the request for minor revisions
(0) 讚! | 百花冰海

作者: alahui2004@126.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2018-07-10 18:55:48 評論於
6 weeks to receive the first review; did not provide a specific status. I didn't have much hope, but I revised it in strict accordance with the editorial opinions. I asked for a reply within 2 months. Receive within 1.5 months. Accepted.

(0) 讚! | alahui2004@126.com

作者: 铁线保胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-07-07 13:34:28 評論於
Do you need an ethical proof?
(0) 讚! | 铁线保胜

作者: 铁线保胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-10 12:03:00 評論於
May I ask if you require an ethical proof?
(0) 讚! | 铁线保胜

作者: 子琳姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-07 10:32:49 評論於
Rejecting the article after 10 days
(0) 讚! | 子琳姑娘

作者: 两仪灵冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-19 12:00:46 評論於
Use the advice and make necessary adjustments. It's not a big problem
(0) 讚! | 两仪灵冬

作者: 沃丽丝阿道夫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-09 20:20:18 評論於
It's time to retreat
(0) 讚! | 沃丽丝阿道夫

作者: 沃丽丝阿道夫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-06 12:38:37 評論於
We have received the reviewers' comments on your paper. The study in its present form did not receive a high enough priority score for publication. However, if you can revise the manuscript in response to the editor and reviewer comments, we will be happy to re-review the manuscript. Please note that the re-submission will be re-reviewed by members of the Editorial Board. If you are prepared to revise the manuscript, please resubmit the revised manuscript within TWO months. For your guidance, editor and reviewer comments are appended below. If you decide to revise the work, please submit a list of changes or a rebuttal against each point raised along with the revised manuscript. To submit a revision, please go to https://ees.elsevier.com/yhupa/ and log in as an author. Your username is: zhaiert@mail2.sysu.edu.cn. If you need to retrieve password details, please go to: http://ees.elsevier.com/yhupa/automail_query.asp
(0) 讚! | 沃丽丝阿道夫

作者: 沃丽丝阿道夫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-03 13:07:39 評論於
Submission in January. Revised on February 19th. Unsure if major or minor revisions required. Revised version still under revision and has not been uploaded since March 19th. What is going on?
(0) 讚! | 沃丽丝阿道夫

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [HUMAN PATHOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*